Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Two cases of EBV infection preceding lymphoma | SpringerLink
Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging | Circulation: Cardiovascular Imaging
NRW doppelt erfolgreich bei Forschungsprogramm für Fachärztinnen und Fachärzte
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Zoo Mentalität Geeignet ann christin heine Hund Darsteller Pfand
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study
Team | IMMEI
Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text
Detection of Damaged DNA Bases by DNA Glycosylase Enzymes | Biochemistry
Immunotherapy as an advance in cancer medicine - Innovations Report
Café Kinderwagen: ein Angebot für Groß und Klein | Spökenkieker - Ihr regionales Anzeigenmagazin
Medicine®
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
UKB NewsRoom | Annkristin Heine
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Generation and functional characterization of MDSC-like cells
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
